Sign In
Buy CLOV
$4.27
-0.0600 (-1.39%)
At Close: Aug 04, 2026
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
04:05pm, Thursday, 26'th Feb 2026
Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-year Achieved industry-leading 2026 AEP growth of 53%
Reviewing Clover Health Investments (NASDAQ:CLOV) & Strata Skin Sciences (NASDAQ:SSKN)
02:06am, Wednesday, 18'th Feb 2026
Strata Skin Sciences (NASDAQ: SSKN - Get Free Report) and Clover Health Investments (NASDAQ: CLOV - Get Free Report) are both small-cap medical companies, but which is the better investment? We will c
Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
04:05pm, Tuesday, 17'th Feb 2026
WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial O
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
04:05pm, Thursday, 29'th Jan 2026
WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its f
Standard BioTools (NASDAQ:LAB) versus Clover Health Investments (NASDAQ:CLOV) Critical Review
01:22am, Wednesday, 28'th Jan 2026
Standard BioTools (NASDAQ: LAB - Get Free Report) and Clover Health Investments (NASDAQ: CLOV - Get Free Report) are both small-cap medical companies, but which is the better business? We will contras
Clover Health (CLOV) Slides As Trump Medicare Advantage Shock And UnitedHealth Earnings Hit Insurer Sentiment
03:43pm, Tuesday, 27'th Jan 2026
Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.
Clover Health Is Undervalued With Clear Signs Of A 2026 Profit Breakout
09:39am, Tuesday, 27'th Jan 2026
Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. CLOV's member retention exceeds 90%, older cohorts generate $217 monthly profit, a
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now
12:11pm, Tuesday, 20'th Jan 2026
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
02:15pm, Thursday, 15'th Jan 2026
Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026
01:10pm, Thursday, 15'th Jan 2026
Clover Health posts 53% AEP PPO membership growth, lifts total members to 153,000, and says the momentum positions it for GAAP net income profitability in 2026.
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
08:30am, Monday, 12'th Jan 2026
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health
Clover Health Investments, Corp. (NASDAQ:CLOV) Given Consensus Rating of “Hold” by Analysts
03:20am, Sunday, 11'th Jan 2026
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) has earned an average recommendation of "Hold" from the five analysts that are currently covering the stock, Marketbeat reports. One i
Here's Why You Should Retain CLOV Stock in Your Portfolio Now
09:31am, Thursday, 18'th Dec 2025
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
04:05pm, Tuesday, 16'th Dec 2025
WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive O
